Highlights Novo Nordisk A/S

Equities

NOVO B

DK0062498333

Pharmaceuticals

Market Closed - Nasdaq Copenhagen Other stock markets 08:50:00 13/05/2026 pm IST			5-day change	1st Jan Change
299.20 ^DKK	+0.91%		+3.07%	-8.01%

15/05	European Equities Traded in the US as American Depositary Receipts Down Sharply in Friday Trading	MT
15/05	Sandoz Lands EU Nod for Insulin Biosimilars Bysumlog, Dazparda	MT

Highlights

14/05	Takeda to cut about 4,500 jobs in fiscal 2026 as it steps up restructuring	RE
13/05	Novo Nordisk Presents Wegovy Pill Clinical Trial Results and Product Updates	CI
12/05	Novo Nordisk A/S Demonstrates Higher Dose Wegovy Achieves Nearly 28% Weight Loss in Early Responders	CI
12/05	India's Dr Reddy's plans generic Ozempic launch in Canada this month, eyes India semaglutide tablet roll-out	RE
12/05	Novo Nordisk A/S Demonstrates Wegovy Delivers Substantial Weight Loss and Health Benefits for Women Across All Menopause Stages	CI
12/05	Hims & Hers plunges as branded weight-loss drug pivot hits results	RE
12/05	Hims & Hers misses revenue estimates as strategy shift hits sales	RE
11/05	Cellular Intelligence Announces Agreement with Novo Nordisk for Global Rights to Clinical-Stage Parkinson's Cell Therapy Program	CI
11/05	Novo Nordisk to Sell Parkinson's Cell Therapy to Startup Cellular Intelligence	DJ
11/05	Cellular Intelligence Acquires Global Rights to Parkinson's Cell Therapy Program from Novo Nordisk	MT
11/05	Novo Nordisk Agrees Divestment of Parkinson's Disease Cell Therapy Program to Cellular Intelligence	MT
11/05	Zuckerberg backed-Cellular Intelligence acquires Novo Nordisk's Parkinson's cell therapy	RE
11/05	Novo Nordisk Agrees Divestment of Parkinson's Disease Cell Therapy Program to Cellular Intelligence	MT
11/05	Cellular Intelligence enters into agreement with Novo Nordisk to acquire STEM-PD	RE
11/05	Novo Nordisk A/S (CPSE:NOVO B) agreed to acquire an unknown minority stake in Cellular Intelligence.	CI
07/05	Novo Nordisk Price Target Rises as BMO Notes Wegovy Pill Uptake, FY26 Guidance	MT
07/05	Novo Nordisk signals openness to further acquisitions in obesity drug space	FW
07/05	Health Care Up as Novo Nordisk Earnings - Health Care Roundup	DJ
06/05	Novo Nordisk Expects Delay for Generic Ozempic in China	MT
06/05	Generic Versions of Novo Nordisk's Ozempic Delayed in China Until April 2027	MT
06/05	Novo Nordisk: The tide has begun to turn
06/05	HEALTH ROUNDS-Researchers gain new insight into how psychedelics affect the brain	RE
06/05	European Midday Briefing : Stocks Advance on Renewed Hopes For Middle East Peace	DJ
06/05	Novo Nordisk A/S Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
06/05	Novo Nordisk Q1 Earnings Fall, Revenue Rises; Raises 2026 Sales Guidance	MT